MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Oldrini, Barbara | - |
dc.contributor.author | Vaquero-Siguero, Nuria | - |
dc.contributor.author | Mu, Quanhua | - |
dc.contributor.author | Kroon, Paula | - |
dc.contributor.author | Zhang, Ying | - |
dc.contributor.author | Galan-Ganga, Marcos | - |
dc.contributor.author | Bao, Zhaoshi | - |
dc.contributor.author | Wang, Zheng | - |
dc.contributor.author | Liu, Hanjie | - |
dc.contributor.author | Sa, Jason K. | - |
dc.contributor.author | Zhao, Junfei | - |
dc.contributor.author | Kim, Hoon | - |
dc.contributor.author | Rodriguez-Perales, Sandra | - |
dc.contributor.author | Nam, Do-Hyun | - |
dc.contributor.author | Verhaak, Roel G. W. | - |
dc.contributor.author | Rabadan, Raul | - |
dc.contributor.author | Jiang, Tao | - |
dc.contributor.author | Wang, Jiguang | - |
dc.contributor.author | Squatrito, Massimo | - |
dc.date.accessioned | 2021-08-30T17:57:10Z | - |
dc.date.available | 2021-08-30T17:57:10Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2020-08-04 | - |
dc.identifier.issn | 2041-1723 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/53806 | - |
dc.description.abstract | Temozolomide (TMZ) is an oral alkylating agent used for the treatment of glioblastoma and is now becoming a chemotherapeutic option in patients diagnosed with high-risk low-grade gliomas. The O-6-methylguanine-DNA methyltransferase (MGMT) is responsible for the direct repair of the main TMZ-induced toxic DNA adduct, the O6-Methylguanine lesion. MGMT promoter hypermethylation is currently the only known biomarker for TMZ response in glioblastoma patients. Here we show that a subset of recurrent gliomas carries MGMT genomic rearrangements that lead to MGMT overexpression, independently from changes in its promoter methylation. By leveraging the CRISPR/Cas9 technology we generated some of these MGMT rearrangements in glioma cells and demonstrated that the MGMT genomic rearrangements contribute to TMZ resistance both in vitro and in vivo. Lastly, we showed that such fusions can be detected in tumor-derived exosomes and could potentially represent an early detection marker of tumor recurrence in a subset of patients treated with TMZ. Chemotherapy resistance in recurrent gliomas is a large hurdle for successful therapy. Here, the authors show that some recurrent gliomas harbour O-6-methylguanine-DNA methyltransferase (MGMT) genomic rearrangements, and in vitro and in vivo these contribute to temozolomide resistance. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | NATURE PUBLISHING GROUP | - |
dc.subject | PROMOTER METHYLATION | - |
dc.subject | RNA-SEQ | - |
dc.subject | GLIOBLASTOMA | - |
dc.subject | TEMOZOLOMIDE | - |
dc.subject | GENE | - |
dc.subject | BENEFIT | - |
dc.title | MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Sa, Jason K. | - |
dc.identifier.doi | 10.1038/s41467-020-17717-0 | - |
dc.identifier.scopusid | 2-s2.0-85089035003 | - |
dc.identifier.wosid | 000561116100001 | - |
dc.identifier.bibliographicCitation | NATURE COMMUNICATIONS, v.11, no.1 | - |
dc.relation.isPartOf | NATURE COMMUNICATIONS | - |
dc.citation.title | NATURE COMMUNICATIONS | - |
dc.citation.volume | 11 | - |
dc.citation.number | 1 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalWebOfScienceCategory | Multidisciplinary Sciences | - |
dc.subject.keywordPlus | PROMOTER METHYLATION | - |
dc.subject.keywordPlus | RNA-SEQ | - |
dc.subject.keywordPlus | GLIOBLASTOMA | - |
dc.subject.keywordPlus | TEMOZOLOMIDE | - |
dc.subject.keywordPlus | GENE | - |
dc.subject.keywordPlus | BENEFIT | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.